Get the Stockscreener App
52.95
1.78%
0.96
After Hours:
52.94
-0.01
-0.02%
Gsk Plc Adr Stock (GSK) Forecast
The Gsk Plc Adr (GSK) stock price forecast for the next 30 days is generally negative, with an average analyst price target of $39.57, representing a -25.26% decrease from the current price of $52.95. The highest analyst price target is $42.64, and the lowest is $36.51.
Note: Our forecast model does not currently account for dividend and stock split events. This means that our forecast may not be accurate for stocks that have recently experienced either of these events.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month GSK Price Target
Average 41.98
(-20.71% Downside)
Is Gsk Plc Adr (GSK) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 40.94 | Neutral |
| STOCH(9,6) | 14.36 | Buy |
| STOCHRSI(14) | 62.02 | Neutral |
| MACD(12,26) | -1.0546 | Sell |
| ADX(14) | 28.69 | Sell |
| William %R | -69.02 | Neutral |
| CCI(14) | -29.77 | Neutral |
Buy: 1
Sell: 2
Neutral: 4
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
53.12
Sell
|
53.23
Sell
|
| MA20 |
55.04
Sell
|
54.33
Sell
|
| MA50 |
54.66
Sell
|
54.05
Sell
|
| MA100 |
51.41
Buy
|
51.51
Buy
|
| MA200 |
45.77
Buy
|
47.39
Buy
|
Buy: 4
Sell: 6
Neutral: 0
Summary: Sell
According to our latest analysis, GSK could be considered a Moderate Sell, with 17 technical analysis indicators signaling 5 Buy signals, 8 signaling Sell signals and 4 Neutral signals. This might not be a good time to consider opening new positions on GSK, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 40.94 indicates that GSK is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 14.36 indicates that GSK is oversold. This indicates that GSK price is at or near the lowest level over a specified lookback period.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 62.02 indicates that GSK is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- ADX (Average Directional Index): The ADX value of The ADX value of 28.69 suggests a moderate trend in the market. While not exceptionally strong, it indicates that there is some directional movement occurring. You should pay attention to this trend but may also look for confirmation from other technical indicators or fundamental factors.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -29.77 indicates that GSK is not in oversold or overbought territory. It suggests a neutral sentiment in the short term.
Long-term GSK price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Gsk Plc Adr financial reports and earnings history, Gsk Plc Adr (GSK) stock could reach $36.95 by 2030, $20.09 by 2040 and $22.78 by 2050. See the projected annual prices until 2050 of the Gsk Plc Adr stock below:
- Gsk Plc Adr (GSK) is expected to reach an average price of $23.89 in 2035, with a high prediction of $24.04 and a low estimate of $21.73. This indicates an $-54.89% rise from the last recorded price of $52.95.
- Gsk Plc Adr (GSK) stock is projected to chart a bullish course in 2040, with an average price target of $17.82, representing an $-66.34% surge from its current level. The forecast ranges from a conservative $17.34 to a sky-high $20.09.
- Our analysts predict Gsk Plc Adr (GSK) to jump -89.79% by 2045, soaring from $3.7509 to an average price of $5.4086, potentially reaching $8.1503. While $3.7509 is the low estimate, the potential upside is significant.
- Gsk Plc Adr (GSK) stock is expected to climb by 2050, reaching an average of $22.37, a $-57.75% jump from its current level. However, a wide range of estimates exists, with high and low targets of $22.78 and $17.60, respectively, highlighting the market's uncertainty.
Gsk Plc Adr Stock (GSK) Year by Year Forecast
Gsk Plc Adr Stock (GSK) Price Forecast for 2026
The predicted value for Gsk Plc Adr (GSK) in 2026 is set at an average of $41.20. Estimates vary from a peak of $46.96 to a trough of $35.43, indicating an -22.20% surge from the present price of $52.95.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| April, 2026 | $36.56 | $36.51 | $42.64 | -30.96% |
| May, 2026 | $39.31 | $35.43 | $39.46 | -25.77% |
| June, 2026 | $39.36 | $37.91 | $39.54 | -25.67% |
| July, 2026 | $42.41 | $38.35 | $42.59 | -19.91% |
| August, 2026 | $43.76 | $41.30 | $43.95 | -17.36% |
| September, 2026 | $43.79 | $42.37 | $45.38 | -17.30% |
| October, 2026 | $44.11 | $42.18 | $44.76 | -16.69% |
| November, 2026 | $44.54 | $44.17 | $46.96 | -15.89% |
| December, 2026 | $41.39 | $41.00 | $45.76 | -21.83% |
Gsk Plc Adr Stock (GSK) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Gsk Plc Adr (GSK) is $46.40, with a high forecast of $64.50 and a low forecast of $28.30. This indicates an -12.37% decrease from the last price of $52.95.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $43.37 | $40.89 | $43.41 | -18.10% |
| February, 2027 | $45.64 | $43.21 | $48.16 | -13.80% |
| March, 2027 | $47.55 | $44.67 | $48.53 | -10.21% |
| April, 2027 | $50.52 | $46.98 | $50.77 | -4.59% |
| May, 2027 | $49.70 | $48.15 | $52.26 | -6.14% |
| June, 2027 | $43.94 | $43.51 | $50.58 | -17.02% |
| July, 2027 | $48.18 | $42.73 | $48.75 | -9.02% |
| August, 2027 | $49.83 | $48.05 | $52.45 | -5.90% |
| September, 2027 | $48.83 | $46.42 | $64.50 | -7.78% |
| October, 2027 | $45.35 | $45.10 | $49.65 | -14.34% |
| November, 2027 | $46.70 | $45.84 | $48.71 | -11.79% |
| December, 2027 | $29.83 | $28.30 | $47.03 | -43.67% |
Gsk Plc Adr Stock (GSK) Price Forecast for 2028
In 2028, Gsk Plc Adr (GSK) is projected to reach an average price of $27.94, with a high projection of $33.60 and a low estimate of $22.29. This indicates an -47.23% fall from the last price of $52.95.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $25.66 | $25.28 | $29.34 | -51.54% |
| February, 2028 | $23.25 | $22.29 | $26.71 | -56.09% |
| March, 2028 | $27.01 | $23.58 | $27.31 | -48.99% |
| April, 2028 | $27.84 | $25.06 | $27.94 | -47.42% |
| May, 2028 | $29.09 | $27.56 | $33.60 | -45.07% |
| June, 2028 | $29.26 | $28.10 | $29.61 | -44.74% |
| July, 2028 | $29.73 | $28.40 | $30.72 | -43.85% |
| August, 2028 | $27.41 | $27.28 | $30.12 | -48.24% |
| September, 2028 | $31.92 | $27.11 | $32.13 | -39.72% |
| October, 2028 | $30.91 | $29.63 | $32.24 | -41.62% |
| November, 2028 | $28.06 | $27.28 | $31.12 | -47.01% |
| December, 2028 | $29.60 | $28.12 | $30.53 | -44.09% |
Gsk Plc Adr Stock (GSK) Price Forecast for 2029
The 2029 price forecast for Gsk Plc Adr Stock (GSK) is $32.80 on average, with a high prediction of $37.94 and a low estimate of $27.67. This represents an -38.05% decrease from the previous price of $52.95.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $29.55 | $27.67 | $30.35 | -44.20% |
| February, 2029 | $28.76 | $27.95 | $29.53 | -45.68% |
| March, 2029 | $31.43 | $28.32 | $31.80 | -40.64% |
| April, 2029 | $30.70 | $29.78 | $32.22 | -42.03% |
| May, 2029 | $28.44 | $27.70 | $31.01 | -46.28% |
| June, 2029 | $30.62 | $28.33 | $30.64 | -42.18% |
| July, 2029 | $31.12 | $29.85 | $31.44 | -41.23% |
| August, 2029 | $33.51 | $30.88 | $35.38 | -36.71% |
| September, 2029 | $36.31 | $33.93 | $36.70 | -31.43% |
| October, 2029 | $36.45 | $35.85 | $37.94 | -31.16% |
| November, 2029 | $33.87 | $33.27 | $37.56 | -36.04% |
| December, 2029 | $35.76 | $34.08 | $37.50 | -32.47% |
Gsk Plc Adr Stock (GSK) Price Forecast for 2030
Gsk Plc Adr Stock (GSK) is expected to reach an average price of $36.47 in 2030, with a high forecast of $46.95 and a low forecast of $25.98. This signifies an -31.13% decrease from the last price of $52.95.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $36.52 | $34.44 | $36.95 | -31.03% |
| February, 2030 | $37.02 | $36.13 | $38.22 | -30.09% |
| March, 2030 | $37.77 | $36.72 | $39.54 | -28.66% |
| April, 2030 | $38.33 | $36.07 | $38.80 | -27.60% |
| May, 2030 | $39.94 | $36.76 | $40.53 | -24.56% |
| June, 2030 | $41.32 | $37.56 | $41.66 | -21.97% |
| July, 2030 | $41.61 | $40.83 | $44.06 | -21.42% |
| August, 2030 | $45.79 | $41.81 | $45.93 | -13.52% |
| September, 2030 | $45.13 | $44.18 | $46.07 | -14.77% |
| October, 2030 | $41.32 | $40.97 | $46.95 | -21.96% |
| November, 2030 | $33.23 | $30.30 | $41.44 | -37.23% |
| December, 2030 | $32.83 | $25.98 | $34.73 | -37.99% |
0.84%
0.41%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):